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  Objective(s): Evaluation of the Sophora alopecuroides var. alopecuroides seed effects on morphine 
withdrawal syndrome in mice and determination of the alkaloid composition of the seed total 
extract. 
Materials and Methods: The effects of the seed total extract, alkaloid fraction and major compound 
matrine on the mice morphine withdrawal syndrome were compared to saline and methadone. Mice 
were made dependent on morphine by morphine sulfate injection 3 times a day for 3 days. The 
withdrawal jumping and diarrhea were induced by administration of naloxone 2 hr after the 10th 
injection of morphine sulfate on the day 4. The total extract (100, 200, 300 mg/kg), alkaloid fraction (5, 
10, 20 mg/kg), matrine (5, 15, 30 mg/kg), methadone (10 mg/kg) or saline were injected 30 min before 
naloxone. All drugs were administered by subcutaneous injection. The total extract alkaloid composition 
was also determined by gas chromatography (GC) and GC-MS analysis.  
Results: All doses of the total extract, alkaloid fraction and matrine as well as methadone 
decreased jumping and diarrhea significantly compared to the saline. The effects of the total 
extract and alkaloid fraction were not significantly different from methadone. But, there were 
significant differences between the effects of matrine and methadone. Matrine, cytisine, 
sophoridine, n-methyl cytisine, sophocarpine and sophoramine were the major alkaloids. There 
was no nicotine in the total extract.   
Conclusion: S. alopecuroides var. alopecuroides suppresses opioid withdrawal with efficacy 
comparable to methadone. Matrine may be one of the alkaloids responsible for the effect of the 
plant.  
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Introduction 
Opioid dependence or addiction is a prevalent   
health and socioeconomic problem. There are 2         
kinds    of pharmacotherapies for opioid dependence: 
detoxification and opioid maintenance treatment (OMT). 
The purpose of detoxification is to provide a safe and 
comfortable withdrawal from drug. OMT aims to induce 
avoidance of illicit drug use.  Many drugs are used                         
for detoxification including tapered methadone, tapered 
methadone plus adjunctive medication, other opioid 
agonists, clonidine, lofexidine, other adrenergic agonists, 
buprenorphine, and symptomatic medications. 
Methadone is the most effective drug used in 
detoxification. Any opioid drug can be used in OMT 
which is also termed opioid replacement therapy or 
agonist substitution. Methadone, buprenorphine and 
injectable diamorphine (heroin) are the drugs usually 
used in OMT. Methadone maintenance is the gold
standard of treatment. New and evolving therapies are 
compared to this standard (1-3). The current 
pharmacotherapies of opioid dependence have 
unfavorable efficacy and safety profile. A substantial 
number of patients do not respond adequately to the 
pharmacotherapies. Thus, novel more effective and safer 
pharmacological treatments for opioid dependence are 
needed (4-6).   
Plants and their bioactive compounds are suitable 
sources for development of new opioid dependence 
pharmacotherapies (7, 8). Sophora alopecuroides L. var. 
alopecuroides (S. alopecuroides) (Leguminosae) is a plant 
widely distributed in Western and Central Asia. It is up to 
1 meter tall perennial herb with rhizome. It has legumes 
5-7 cm long, 7-8 mm diameter and cylindrical                       
with spherical seeds (9). The plant seed is administered 
orally in the Iranian traditional medicine for the 
treatment of opium, heroin, methamphetamine and 
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nicotine addiction, diarrhea and pain. Specifically, the 
Iranian therapists use the plant for the control of opioid 
withdrawal syndrome and OMT. The plant demonstrates 
good human safety profile (no adverse effects) in the 
usual oral doses (up to 5 g per day of the seed dried 
aqueous extract). Quinolizidine alkaloids are the main 
bioactive compounds of S. alopecuroides. More than 20 
kinds of alkaloids have been isolated from the plant 
including matrine, oxymatrin, sophocarpine, 
oxysophocarpine, cytisine, sophoramine, sophorodine, 
nicotine and others. The alkaloids have shown 
anticancer, antimicrobial, immunological, nervous 
system, cardiovascular and gastrointestinal effects in the 
pharmacological studies (10, 11). Varenicline is an 
analogue of cytisine. Cytisine and varenicline are both 
effective aids to smoking cessation (12). The major 
alkaloid of S. alopecuroides matrine has a variety                          
of biological activities including analgesic, anti-
inflammatory, anti-arrhythmic, anti-tumor, anti-diarrhea, 
antiobesity and immunomodulatory effects (13-15). 
Matrine has been widely used in China for the treatment 
of cancer, hepatic, cardiac and skin diseases (16). Of note, 
the phytochemistry of the Iranian S. alopecuroides has 
not been examined so far. The only study relative to the 
biological effects of the Iranian S. alopecuroides has 
demonstrated that it has analgesic effect in the rat 
formalin test (17). Moreover, there has been no study 
concerning the effects of S. alopecuroides on drug 
dependence.   
Considering the above data, in the present study, the 
effects of a standardized extract of the Iranian S. 
alopecuroides, its alkaloid fraction and major compound 
matrine on the mice morphine withdrawal syndrome 
were evaluated and compared with saline and 
methadone. 
 
Materials and Methods 
Plant materials 
The seeds of S. alopecuroides L. var. alopecuroides 
(Leguminosae) were collected at fruiting stage from 
Raviz, 60 km Northwest of Rafsanjan, province of 
Kerman, Iran. The voucher specimen (number 27235) 
was deposited in the Tehran University Central 
Herbarium. 
 
Total extract 
The seeds of plant were dried, powdered (500 g) 
and macerated with a 90% ethanol solution for 3 days 
with three changes of the solution. The resulting extract 
was filtered and evaporated under vacuum into a dried 
powder extract (30 g, 6%).  
 
Extraction of alkaloids 
Alkaloid extraction was carried out as described by 
Kamada et al (1986) (18): 200 ml of CHCl3- Me OH- 
NH4OH (15: 5: 1) was added to 600 mg of total extract, 
sonicated for 10 min. After filtration, the residue was 
washed twice with 200 ml of solution. The pooled 
filtrate was evaporated to dryness. To the residue, 5 ml 
of CHCl3 and 2 ml of 1 N H2SO4 were added and then the 
solution was mixed. The CHCl3 phase was removed and 
the H2SO4 phase was adjusted to pH 10 with 28% 
NH4OH. From the solution, alkaloids were extracted 
once with 2 ml and twice with 1 ml of CHCl3. The 
combined extracts were filtered after adding anhydrous 
Na2SO4. The combined filtrates were evaporated to 
dryness at 40 °C (265 mg).     
 
GC (gas chromatography) and GC-MS (gas 
chromatography-mass spectrometry) analysis 
The extraction of alkaloids was analyzed on a 
Younglin Acm 600 instrument with an FID detector 
operated with a split/splitless injector (Younglin, 
Korea) and DB-5 capillary column, 30 m × 0.25 mm i.d., 
0.25 μm film thicknesses (Agilent, USA). 
Carrier gas: He, linear velocity (u): 30 cm/sec, flow: 
0.8 ml/min Injection temperature: 290 ˚C. Injection 
volume: 1.0 μl. Injection mode: Split (1:50). 
Temperature program: 50 ˚C for min, rising at 3 ˚C /min 
to 240 ˚C, then rising at 15 ˚C/min to 300 ˚C, held at                
300 ˚C for 3 min. FID (290 ˚C): H2 flow: 50 ml/min; air 
flow: 400 ml/min. 
GC/MS analysis was performed on an Agilent 
6890/5973 N instrument and DB-5 capillary column 
(30 m × 0.25 mm i.d., 0.25 μm film thickness). Carrier 
gas: He, Linear velocity (u): 32.4 cm/sec, flow: 0.8 
ml/min. Injection temperature: 290 ˚C. Injection 
volume: 1.0 μl. Injection mode: split (1:10). 
Temperature program: 50 ˚C, for 5 min, rising at                              
3 ˚C/min to 240 ˚C, then rising at 15 ˚C/min to 300 ˚C, 
held at 300 ˚C for 3 min. MS interface temperature: 290 
˚C, MS mode: EI, Ionization voltage: 70 eV; mass range: 
40-500 u; scan speed: 3.18 scans/sec; interval: 0.50 sec 
(2 Hz). Data handling was conducted using a Chem. 
Station (Agilent). 
 
Identification of the components  
The compounds of the extraction of alkaloids were 
identified by comparison of their retention indices, 
which were calculated by using the retention times of 
injected n-alkanes (C8–C28) (obtained from Fluka) 
with the same chromatographic conditions, along with 
the fragmentation patterns of the mass spectra with 
those reported in the literatures and the published 
mass spectra or WILEY library (19-22). The percentage 
of the identified compounds was calculated based on 
GC peak areas without any correction factors. 
 
Drugs 
Morphine sulfate and methadone hydrochloride 
were purchased from the Darou Pakhsh 
Pharmaceutical Company (Tehran, Iran). Naloxone 
hydrochloride and matrine were obtained from the 
Sigma-Aldrich and Ningxia Zijinghua companies 
respectively. For dilution, all drugs and extracts were 
dissolved in normal saline. The drugs and extracts were 
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prepared immediately before use and injected 
subcutaneously in a volume of 5 ml/kg. The doses of 
total extract, alkaloid fraction, matrine and methadone 
were as follows. Total extract: 100, 200 and 300 mg/kg; 
alkaloid fraction: 5, 10 and 20 mg/kg; matrine: 5, 15 
and 30 mg/kg; methadone: 10 mg/kg. 
 
Animals 
Male albino mice weighing between 25-30 g 
respectively from our own breeding colony were used. 
The mice were maintained at a temperature of 22-25 ˚C 
on a 12 hr dark-light cycle. The animals had access to 
standard rodent feed and water ad libitum. The number 
of animals used for each dose of the extracts or drugs 
was 10. All animals were used only once.  
 
Animal study 
The effects on opioid withdrawal were evaluated 
using a method described previously (23). To induce 
morphine dependence in the mice, morphine was given 
with the following dosage schedule. Morphine was 
injected thrice a day at 9:30, 13:30 and 17:30 hr using 
the doses 50, 50 and 75 mg/kg respectively for 3 days. 
The higher afternoon dose was aimed to minimize 
overnight withdrawal. Moreover, a 50 mg/kg dose of 
morphine was given in the 4th day morning (2 hrs 
before naloxone injection). Hyperactivity and Straub 
tail effect were noted after morphine injection. Weight 
loss of 10% without any animal death was also 
observed. 
Naloxone (2 mg/kg) was given 2 hrs after the last 
injection of morphine in the 4th day. Subsequently, the 
animals were placed singly on a piece of blotting paper 
in a cylindrical glass (25 cm in diameter, 40 cm height) 
for 30 min. Naloxone immediately caused morphine 
withdrawal signs as jumping and diarrhea. The number 
of jumps and feces weight during the 30 min period 
was recorded for each animal. The total extract, alkaloid 
fraction and matrine as active treatments, methadone 
(positive control) or saline (negative control) were 
injected 30 min before naloxone. This study was 
conducted according to the European Community 
Guidelines (EEC Directive of 1986; 86/609/EEC) for 
laboratory animal use and care.  
 
Statistical analysis 
The animal study results were presented as mean 
+standard error of the mean (SEM). One way analysis of 
variance (ANOVA) followed by Tukey post hoc test was 
used for data analysis. Significance level was set at 0.05. 
 
Results  
GC and GC-MS analysis 
Alkaloid extraction was analysed by capillary GC 
and GC-MS and the main compounds were 
determined via areas under the peaks. Matrine 
(23.2%), cytisine (20.9%), sophoridine (17.2%), n-
methyl cytisine (13.4%), sophocarpine (9.1%) and 
sophoramine (1.2%), were identified as the main 
components in the alkaloid extract (Table 1). There 
was no nicotine in the alkaloid extract. 
 
Animal study  
All doses of the total extract, alkaloid fraction and 
matrine as well as methadone decreased jumping 
and diarrhea significantly compared to the saline 
(Figures 1-6). The effects of the total extract and 
alkaloid fraction were not significantly different from 
methadone. But, there were significant differences 
between the effects of matrine and methadone.  
 
 
 
 
Table 1. The major compounds (in terms of percentage of the 
total alkaloid content) identified in the alkaloid extraction of 
Sophora alopecuroides var. alopecuroides 
 
No. Compoundsa 
 
Rtb 
 
KIc 
Percentage of the 
total alkaloid content 
1 n- methyl cytisine 55.3 
1965 
13.4 
2 cytisine 56.1 
1994 
20.9 
3 sophocarpine 64.5 
2235 
9.1 
4 sophoridine 65.1 
2246 
17.2 
5 matrine 66.2 
2266 
23.2 
6 sophoramine 69.8 
2451 
1.2 
 
a Compounds listed in order of elution from the HP-5 MS column;              
b Retention times (as min); c Kovats indices on a DB-5 column in 
reference to n-alkanes 
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Figure 1. Effects of saline (Sal), methadone (Met) (10 mg/kg, SC), 
Sophora alopecuroides var. alopecuroides total extract (TE)                 
(100 mg/kg, 200 mg/kg, 300 mg/kg, SC) on jumping induced by 
naloxone (2 mg/kg, SC) in groups of 10 morphine dependent mice. 
Data are given as mean+SEM. P-value<0.001 for all groups 
compared to the saline. The asterisked columns are significantly 
different from the saline 
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Figure 2. Effects of saline (Sal), methadone (Met) (10 mg/kg, SC), 
Sophora alopecuroides var. alopecuroides total extract (TE) (100 mg/kg, 
200 mg/kg, 300 mg/kg, SC) on diarrhea induced by naloxone (2 mg/kg, 
SC) in groups of 10 morphine dependent mice. Data are given as mean ± 
SEM. P-value<0.001 for all groups compared to the saline. The asterisked 
columns are significantly different from the saline 
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Figure 3. Effects of saline (Sal), methadone (Met) (10 mg/kg, SC), 
Sophora alopecuroides  var. alopecuroides alkaloid fraction (AF) (5 
mg/kg, 10 mg/kg, 20 mg/kg, SC) on jumping induced by naloxone (2 
mg/kg, SC) in groups of 10 morphine dependent mice. Data are given 
as mean±SEM. P-value<0.001 for all groups compared to the saline. 
The asterisked columns are significantly different from the saline 
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Figure 4. Effects of saline (Sal), methadone (Met) (10 mg/kg, SC), 
Sophora alopecuroides var. alopecuroides alkaloid fraction (AF)              
(5 mg/kg, 10 mg/kg, 20 mg/kg, SC) on diarrhea induced by naloxone 
(2 mg/kg, SC) in groups of 10 morphine dependent mice. Data are 
given as mean±SEM. P-value < 0.001 for all groups compared to the 
saline. The asterisked columns are significantly different from the 
saline 
 
 
 
Figure 5. Effects of saline (Sal), methadone (Met) (10 mg/kg, SC), matrine 
(Mat) (5 mg/kg, 15 mg/kg, 30 mg/kg, SC) on jumping induced by naloxone 
(2 mg/kg, SC) in groups of 10 morphine dependent mice. Data are given as 
mean ± SEM.   P-value=0.018 for Mat (5 mg/kg) and P-value<0.001 for the 
other groups compared to the saline. The asterisked columns are 
significantly different from the saline 
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Figure 6. Effects of saline (Sal), methadone (Met) (10 mg/kg, SC), 
matrine (Mat) (5 mg/kg, 15 mg/kg, 30 mg/kg, SC) on diarrhea 
induced by naloxone (2 mg/kg, SC) in groups of 10 morphine 
dependent mice. Data are given as mean±SEM. P-value=0.004 for 
Mat (5 mg/kg) and             P-value<0.001 for the other groups 
compared to the saline. The asterisked columns are significantly 
different from the saline 
 
Discussion 
The present study is the first study evaluating the 
alkaloid composition of the Iranian S. alopecuroides 
seeds. The results indicate that matrine, cytisine, 
sophoridine, n-methyl cytisine, sophocarpine and 
sophoramine are the major constituents of the Iranian 
S. alopecuroides seeds. The Iranian S. alopecuroides has 
no nicotine. This is in contrast to the Chinese S. 
alopecuroides which contains nicotine (24). Also, the S. 
alopecuroides total extract and alkaloid fraction 
profoundly reduce the signs of morphine withdrawal. 
The inhibitory effect of the plant total extract and 
alkaloid fraction on the opioid withdrawal syndrome is 
comparable to methadone. Matrine alleviates the 
morphine withdrawal syndrome markedly less than 
the total extract and alkaloid fraction. The significant 
difference between the effects of matrine and 
methadone shows that the effect of the plant cannot be 
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totally attributed to matrine and the other alkaloids 
besides matrine may also be involved in the plant 
effect. Moreover, the results explain the traditional use 
of the plant for the treatment of opioid dependence in 
Iran. The effects of plants from numerous families have 
been examined in opioid dependence and withdrawal 
syndrome so far (7, 8). However, there has been no 
study regarding the family Leguminosae and the genus 
Sophora. Further, the effects of the constituents of S. 
alopecuroides in the animal models and clinical trials of 
opioid dependence have not been evaluated. The 
mechanisms of the inhibitory effects of the S. 
alopecuroides total extract and alkaloid fraction and 
matrine on the morphine withdrawal syndrome were 
not investigated in the present study. Of note, cytisine is 
an agonist of nicotinic receptors (25-28). Agonists of 
nicotinic receptors can suppress opioid withdrawal  
(27, 28). Thus, the nicotinic receptor agonistic action of 
the s. alopecuroides cytisine may have some role in               
the morphine withdrawal inhibitory effect of                    
S. alopecuroides. Several studies have reported 
involvement of μ and κ opioid receptors in the 
analgesic effect of matrine in mice (29-31).  However, a 
study concluded that matrine has no affinity for μ, κ 
and δ opioid receptors in vitro and its analgesic effect in 
mice may be through cholinergic activation rather than 
acting on opioid receptors directly (32). Therefore, the 
matrine present in S. alopecuroides may alleviate 
morphine withdrawal by activation of nicotinic 
receptors. Moreover, in another study, the plant total 
extract did not cause Straub tail effect in mice. This 
indicates that it does not activate µ2 opioid receptors 
and thus may not produce the opioid adverse effects 
caused by µ2 receptor activation (physical dependence, 
respiratory depression and constipation) (17). The 
just-mentioned study suggests that the plant can be 
regarded as a non-opioid agent. In practice, there has 
also been no report showing the addictive potential of 
the plant despite its use for several thousand years. 
Notably, the plant may be of significance given                     
the paucity of medications approved for opioid 
detoxification and relapse prevention, particularly non-
opioid medications. Also, the effectiveness of the plant 
comparable to methadone in the present study shows 
the possible clinical value of the plant. In conclusion, 
the promising results of the current study warrant 
conduction of clinical trials regarding the efficacy                   
and safety of the plant in opioid detoxification and 
maintenance treatment. Further, more studies 
addressing identification of the components and 
mechanisms mediating the inhibitory effect of the plant 
on the morphine withdrawal syndrome are needed. 
 
Conclusion 
S. alopecuroides controls morphine withdrawal 
syndrome to a degree comparable to methadone. Matrine 
may be one of the alkaloids involved in the effect of S. 
alopecuroides.   
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